OPTIMA trial

TARRYTOWN, N.Y., August 19, 2026 Regeneron Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved...

SOUTH SAN FRANCISCO, California, 21 May 2026 Veracyte, Inc. announced that major Phase III clinical trial results involving its...